Literature DB >> 19754749

The ecology of the Zygomycetes and its impact on environmental exposure.

M Richardson1.   

Abstract

Zygomycetes are unique among filamentous fungi in their great ability to infect a broader, more heterogeneous population of human hosts than other opportunistic moulds. Various members of the Zygomycetes have been implicated in zygomycosis, although those belonging to the family Mucoraceae are isolated more frequently than those of any other family. The environmental microbiology literature provides limited insights into how common zygomycetes are in the environment, and provides a few clues about which ecological niches these fungi are found in. Mucorales are thermotolerant moulds that are supposedly ubiquitous in nature and widely found on organic substrates, including bread, decaying fruits, vegetable matter, crop debris, soil between growing seasons, compost piles, and animal excreta. The scientific and medical literature does not support this generalization. Sporangiospores released by mucorales range from 3 to 11 microm in diameter, are easily aerosolized, and are readily dispersed throughout the environment. This is the major mode of transmission. However, there are very few data concerning the levels of zygomycete sporangiospores in outdoor and indoor air, especially in geographical areas where zygomycosis is particularly prevalent. Airborne fungal spores are almost ubiquitous and can be found on all human surfaces in contact with air, especially on the upper and lower airway mucosa. Inhalation of sporangiospores must be a daily occurrence. Surprisingly, members of the Mucorales are very rarely found in nasal mucus, suggesting that spores in the mucus of airway mucosa are cleared by mucociliary transport or that there is a low level of airborne contamination. Zygomycetes are found occasionally in water-damaged buildings, as demonstrated by air-sampling, and analysis of settled dust by quantitative PCR. Moreover, inhalation of sporangiospores in dust has been linked to outbreaks of rhinocerebral or pulmonary zygomycosis due to excavation, construction, or contaminated air-conditioning filters. Whereas most zygomycete infections are community-acquired, nosocomial acquisition due to percutaneous routes of exposure is very important. Sporadic cases, and pseudo-outbreaks, have been linked to contaminated bandages and adhesive dressings, needles, and tongue depressors used to construct splints for intravenous and arterial cannulation sites in preterm infants. Insect bites or stings have been implicated in disease transmission in cases of cutaneous and subcutaneous zygomycosis, e.g. diseases caused by the Entomophthorales. Traumatic implantation of spores in dirt or in contaminated water, e.g. as occurred during the Asian tsunami, has led to infection in multiple patients.

Entities:  

Mesh:

Year:  2009        PMID: 19754749     DOI: 10.1111/j.1469-0691.2009.02972.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  58 in total

Review 1.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  Successful treatment of gastrointestinal mucormycosis in an adult with acute leukemia: case report and literature review.

Authors:  A Alghamdi; A Lutynski; M Minden; C Rotstein
Journal:  Curr Oncol       Date:  2017-02-27       Impact factor: 3.677

3.  Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies.

Authors:  Maheen Z Abidi; Muhammad R Sohail; Nathan Cummins; Mark Wilhelm; Nancy Wengenack; Lisa Brumble; Harshal Shah; Donna Jane Hata; Ann McCullough; Amy Wendel; Holenarasipur R Vikram; Shimon Kusne; Mark Litzow; Louis Letendre; Brian D Lahr; Eric Poeschla; Randall C Walker
Journal:  Mycoses       Date:  2014-07-18       Impact factor: 4.377

Review 4.  Human Pathogenic Entomophthorales.

Authors:  Raquel Vilela; Leonel Mendoza
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

5.  Fatal Pulmonary Mucormycosis due to Rhizopus homothallicus.

Authors:  Fabrice Compain; Nawel Aït-Ammar; Françoise Botterel; Laure Gibault; Francoise Le Pimpec Barthes; Eric Dannaoui
Journal:  Mycopathologia       Date:  2017-06-03       Impact factor: 2.574

6.  Bacterial and protozoan dynamics upon thawing and freezing of an active layer permafrost soil.

Authors:  Morten Schostag; Anders Priemé; Samuel Jacquiod; Jakob Russel; Flemming Ekelund; Carsten Suhr Jacobsen
Journal:  ISME J       Date:  2019-01-28       Impact factor: 10.302

7.  Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients.

Authors:  Simple Bhadania; Neena Bhalodiya; Yashendra Sethi; Nirja Kaka; Swati Mishra; Neil Patel; Asad Ullah Wasim; Saumya S Joshi; Kenisha Shah
Journal:  Cureus       Date:  2021-12-21

Review 8.  The Consequences of Our Changing Environment on Life Threatening and Debilitating Fungal Diseases in Humans.

Authors:  Norman van Rhijn; Michael Bromley
Journal:  J Fungi (Basel)       Date:  2021-05-07

9.  Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.

Authors:  Farzad Pakdel; Kazem Ahmadikia; Mohammadreza Salehi; Azin Tabari; Rozita Jafari; Golfam Mehrparvar; Yasaman Rezaie; Shahin Rajaeih; Neda Alijani; Aleksandra Barac; Alireza Abdollahi; Sadegh Khodavaisy
Journal:  Mycoses       Date:  2021-07-01       Impact factor: 4.931

10.  Imaging features of perineural and perivascular spread in rapidly progressive rhino-orbital-cerebral mucormycosis: A case report and brief review of the literature.

Authors:  Karol Galletta; Concetta Alafaci; Ferdinando Stagno D'Alcontres; Mormina Enrico Maria; Marco Cavallaro; Giorgia Ricciardello; Sergio Vinci; Giovanni Grasso; Francesca Granata
Journal:  Surg Neurol Int       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.